全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1373038-60-8 | 4-(5-Methyl-3-phenyl-4-isoxazolyl)-N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]benzenesulfonamide | C32H25N3O6S2 |
| 1373215-15-6 | N-[(3R,4S)-3,4-Dihydro-3-[[(methylamino)carbonyl]oxy]-6-[4-(3-oxetanyl)-1-piperazinyl]-2H-1-benzopyran-4-yl]-4-fluorobenzamide | C25H29FN4O5 |
| 1373232-19-9 | (R)-Benzyl 2-methyl-3-oxopiperazine-1-carboxylate | C13H16N2O3 |
| 1373232-22-4 | (2S)-2-Methyl-3-oxo-1-piperazinecarboxylic acid phenylmethyl ester | C13H16N2O3 |
| 1373232-85-9 | 2-Amino-4-carboxybenzeneacetic acid | C9H9NO4 |
| 1373253-20-3 | 4-Imidazolidinone hydrochloride | C3H6N2O.HCl |
| 1373253-28-1 | 4-Oxo-3-piperidinecarbonitrile hydrochloride | C6H8N2O.HCl |
| 1373255-08-3 | (2S)-2-(Aminomethyl)-4-morpholinecarboxylic acid 1,1-dimethylethyl ester ethanedioate (1:1) | C10H20N2O3.C2H2O4 |
| 1373255-09-4 | (S)-4,4-Difluoropyrrolidine-2-carboxylic acid 2,2,2-trifluoroacetate | C5H7F2NO2.C2HF3O2 |
| 1373321-04-0 | 1R-Dapagliflozin;(2R,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | C21H25ClO6 |
| 1373422-53-7 | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine | C22H23N5O2 |
| 1373423-53-0 | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine ethyl ester | C24H27N5O2 |
| 1373503-65-1 | Tert-butyl 3,3-difluoro-4-formylpiperidine-1-carboxylate | C11H17F2NO3 |
| 1373615-35-0 | 1-[4-(5'-Chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl)-1-piperazinyl]-3-(methylsulfonyl)-1-propanone | C20H25ClN4O3S |
| 1373764-75-0 | 2-(4-Hydroxyphenyl)-1-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)ethanone;YH-306 | C19H18N2O2 |
| 1373869-89-6 | (E)-2-(5-(cyanoimino)-1-propylpyrrolidin-2-yl)acetic acid | C10H15N3O2 |
| 1373881-94-7 | 3-Bromo-5-tert-butylphenylboronic acid | C10H14BBrO2 |
| 1374030-19-9 | (11bS)-4-Hydroxy-2,6-bis(4-methoxyphenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C34H25O6P |
| 1374248-77-7 | Ubrogepant;(3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide | C29H26F3N5O3 |
| 1374258-43-1 | 5-Bromo-7-(trifluoromethyl)-1H-indazole | C8H4BrF3N2 |
| 1374328-81-0 | 1-(Trifluoromethyl)-3-cyclopentene-1-carboxylic acid | C7H7F3O2 |
| 1374507-23-9 | N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]carbamic acid 1,1-dimethylethyl ester | C16H16ClF3N4O2 |
| 1374507-25-1 | N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide | C14H10ClF3N4O |
| 1374598-80-7 | (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid hydrate (2:1) | 2(C29H32O7S).H2O |
| 1374601-40-7 | BRD 4770;2-(Benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-carboxylic acid methyl ester | C25H23N3O3 |
| 1374639-75-4 | LEE011 succinate | C23H30N8O.C4H6O4 |
| 1374639-76-5 | 3-[2-Chloro-4-(cyclopentylamino)-5-pyrimidinyl]-2-propyn-1-ol | C12H14ClN3O |
| 1374639-77-6 | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-methanol | C12H14ClN3O |
| 1374639-78-7 | tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | C28H38N8O3 |
| 1374639-79-8 | Butanedioic acid, compd. with 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide hydrate (1:1:?) | C23H30N8O.C4H6O4.x(H2O) |
| 1374640-70-6 | N-[3-[[2-[[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide;Co 1686 | C27H28F3N7O3 |
| 1374652-05-7 | 5-Amino-6-methyl-2-pyrazinecarbonitrile | C6H6N4 |
| 1374653-45-8 | 4-Fluoro-4-piperidinecarbonitrile hydrochloride (1:1) | C6H9FN2.HCl |
| 1374658-52-2 | 1-Boc-3-fluoroazetidine-3-carbaldehyde | C9H14FNO3 |
| 1374692-34-8 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-5-iodo-2'-O-methyluridine 3'-acetate | C33H33IN2O9 |
| 1374759-84-8 | 3'-(9H-Carbazol-9-yl)-[1,1'-biphenyl]-4-amine;4-(3-carbazol-9-ylphenyl)aniline | C24H18N2 |
| 1374828-69-9 | alpha,alpha,3-Trimethyl-4-[[4-(methylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1H-pyrazole-1-acetonitrile | C14H16F3N7 |
| 1374853-91-4 | Pembrolizumab;Keytruda; Lambrolizumab; Lanbrolizumab; MK 3475; Merck 3475 | C6504H10004N1716O2036S46 |
| 1374973-19-9 | tert-butyl (1S,2S)-2-amino-3,3-difluorocyclohexylcarbamate | C11H20F2N2O2 |
| 1374975-29-7 | 2,3-Difluoro-1-methyl-4-(trans-4-propylcyclohexyl)benzene | C16H22F2 |
| 1374985-05-3 | (betaR)-beta-Amino-2,4,5-trifluorobenzenebutanoic acid methyl ester hydrochloride (1:1) | C11H12F3NO2.HCl |
| 1375004-39-9 | Bortezomib Isoamyl Impurity;N-((R)-1-(((R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | C29H39BN4O4 |
| 1375064-70-2 | 1-(3-Bromo-4-chloro-1H-indol-1-yl)ethanone | C10H7BrClNO |
| 1375066-73-1 | 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | C4H6N4OS |
| 1375068-74-8 | 5-Bromo-2-fluoro-1-methyl-3-nitrobenzene | C7H5BrFNO2 |
| 1375184-43-2 | B-1H-Benzimidazol-2-ylboronic acid | C7H7BN2O2 |
| 1375301-68-0 | 2-Chloro-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine | C7H6ClN3O |
| 1375301-91-9 | 2-(Cyclopropyl)pyrimidine-5-boronic acid pinacol ester;2-Cyclopropylpyrimidin-5-ylboronic acid pinacol ester; 2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | C13H19BN2O2 |
| 1375302-99-0 | 3-(Benzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;3-phenylmethoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C18H22BNO3 |
| 1375325-64-6 | Chloro(2-dicyclohexylphosphino-2',6'-dimethoxy-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | C38H45ClNO2PPd |